Company / R&D per Share
Imunon, Inc. R&D per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.14
FY2023
5-year range
$0.14 / $4.18
FY2019-FY2023
Trend
-92.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 7 years, ranging from $0.14 in FY2023 to $4.18 in FY2021.
Based on SEC 10-K filings.
0.14 in FY2023 with a 5-year CAGR of -29.1%.
Declined from $4.18 to $0.14 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -37.7%
- 5-Year CAGR
- -29.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, r&d per share decreased 92.6% year-over-year.
- Peak r&d per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.14 | -92.6% |
| FY2022 | $1.84 | -56.0% |
| FY2021 | $4.18 | +644.2% |
| FY2020 | $0.56 | -10.8% |
| FY2019 | $0.63 | -16.8% |
| FY2018 | $0.76 | +61.6% |
| FY2015 | $0.47 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026